Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Booth

Adult Reconstructive Orthopaedic Surgery Philadelphia, PA Medical Doctor

NPI 1932140266 CMS profile 177835

601 Walnut St, Ste L50, Philadelphia, PA 19106

Open in the dashboard

General payments

$14,963,837

36 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Booth of Philadelphia, PA is reported in the CMS Open Payments database as having received $14,963,837 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $178 2
2024 General $183 1
2023 General $8,459,144 4
2022 General $1,564,809 8
2021 General $2,009,231 7
2020 General $1,435,403 7
2019 General $1,494,888 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Booth
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Robert Booth were reported at $178. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Robert Booth Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $1,494,888 $1,416 $292–$9,336 $163
2020 $1,435,403 $647 $141–$6,474 $114
2021 $2,009,231 $1,073 $211–$6,497 $132
2022 $1,564,809 $1,217 $236–$6,299 $149
2023 $8,459,144 $1,082 $246–$6,818 $160
2024 $183 $1,575 $323–$8,944 $164
2025 $178 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $14,963,753 31 payments
  2. DePuy Synthes Sales Inc. $60 3 payments
  3. Smith+Nephew, Inc. $12 1 payment
  4. Heraeus Medical, LLC. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $14,961,442 26 payments
  2. Consulting Fee $1,900 2 payments
  3. Food and Beverage $312 7 payments
  4. Education $183 1 payment
Products named General payments · program years 2019–2025
  1. Persona Knees $10,024,066 12 payments
  2. Persona Knees $2,930,227 10 payments
  3. Persona Knees $1,825,450 4 payments
  4. Persona Revision $183,781 3 payments
  5. ROSA $158 1 payment
  6. MONOVISC Sports Early Intervention $40 2 payments
  7. MONOVISC Sports Early Intervention $20 1 payment
  8. Allevyn Life $12 1 payment
  9. Acticoat Range $12 1 payment
  10. PALACOS $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$293,418

Of which drugs: $10,139

Medicare patients

632

Average age 74

Services billed

18,543

412 women, 220 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 25%
Depression 24%
Osteoporosis 20%
Chronic kidney disease 18%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 96 16,280 $1,672
Injection, methylprednisolone acetate, 20 mg J1020 Office 11 68 $341
Injection, methylprednisolone acetate, 40 mg J1030 Office 16 63 $317

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record